@haspete
although you may be right on cursory short term technical retracement, i have to disagree with your flippant statement on 'no news' going forward for PNV, are you mad?
announcements over the next 6-12 months:
1) final details of breast recon agreement with motiva/ establishment group over next few months
2) finalisation of further TGA approval through the new australian ITP pathway giving reciprocal CE mark approval for europe and SE asia
3) doubling of revenue quarter on quarter, cash burn reducing and transitioning to cash-flow positive
4) progress of the BARDA clinical trial in US
5) announcement of entry into new international markets
6) announcement of new US hospitals stocking PNV product
7) announcements regarding the development and commercialisation of a pnv product for the massive hernia repair market
8) ? surprise takeover offer a big pharma (always possible at this point in the growth curve from R&D to commercialisation) and especially at this point in the economic cycle where M&A activity is increasing.
so 'no news' going forward huh? think again buddy.
PNV - Chart, page-234
-
- There are more pages in this discussion • 19,911 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.07 |
Change
0.030(1.47%) |
Mkt cap ! $1.429B | |||
| Open | High | Low | Value | Volume |
| $2.11 | $2.12 | $2.05 | $2.783M | 1.335M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 19976 | $2.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.07 | 9633 | 3 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| PNV (ASX) Chart |